PeptideStack
5.2kquestions
20kanswers
220users

How does MKM compare to Tianjin Finder Chemical on documentation quality?

Asked 7 Jan 2025Modified 18 months agoViewed 20k times
11

Setup, so nobody has to ask: MKM · Tianjin Finder Chemical.

I am trying to choose between two options that are usually discussed as though only one exists.

I am not optimising for price, but I am not indifferent to it either.

What does each option buy me, and what does it cost me?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
shareeditfollowflag
UM
askedu100_marks52k377 Jan 2025
7Do you have a certificate in front of you, or are you asking before requesting one? – kwn_analytical 6 months ago
add a comment

2 Answers

Sorted by votes
28

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Cost per milligram, adjusted honestly

StepValueNote
Vial price, 10 mg nominal£34.00As advertised
Nominal cost per mg£3.4034 ÷ 10
Measured content9.2 mgIndependent content assay
Cost per actual mg£3.7034 ÷ 9.2
Dead-space loss, 20 draws4 %80 µL of a 2 mL fill
Cost per delivered mg£3.853.70 ÷ 0.96
First vial, with £110 assay£14.85Testing dominates a single vial

More usefully, content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
VF
answeredvial_five12k176 Feb 2025
6This should be linked from the help pages. – tenth_of_a_unit 3 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
20

In practice, a single member running three suppliers on one method is worth more than thirty members running one supplier each.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Price per milligram of measured peptide, not per milligram of label claim.

edited 3 Feb 2025 by tobias_maartens — added the method parameters

shareimprove this answerflag
TM
answeredtobias_maartens171k35826 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.